Invesco Mortgage Capital (IVR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Net income per common share was $0.63 for Q3 2024, reversing a prior loss, with earnings available for distribution at $0.68 per share and book value per share rising 1.1% to $9.37.
Economic return for the quarter was 5.4%.
Announced intention to redeem all Series B Preferred Stock and repurchased Series C Preferred Stock to optimize capital structure.
Issued $88.5 million of common stock under the at-the-market program.
Portfolio primarily comprised agency RMBS and agency CMBS, with agency RMBS representing 87% of the portfolio.
Financial highlights
Net income attributable to common stockholders was $35.3 million for Q3 2024 ($0.63 per share).
Book value per common share was $9.37 as of September 30, 2024, up 1.1% QoQ but down 6.3% year-to-date.
Earnings available for distribution per share was $0.68, down from $0.86 in Q2 2024.
Debt-to-equity and economic debt-to-equity ratios were both 6.1x at quarter end.
Unrestricted cash and unencumbered investments totaled $521 million at quarter end.
Outlook and guidance
Disinflationary trends and anticipated Fed easing are expected to support a steeper yield curve and lower volatility, benefiting agency RMBS.
Risks include reversal of disinflation, labor market improvement, inflation, fiscal policy, and short-term funding pressures.
Constructive outlook on agency RMBS and agency CMBS due to attractive valuations and supportive technicals.
Book value per common share as of October 31, 2024, estimated between $8.42 and $8.76.
Latest events from Invesco Mortgage Capital
- Director elections, executive pay, and auditor ratification up for vote at the 2026 annual meeting.IVR
Proxy filing20 Mar 2026 - Board refreshment, strong returns, and robust governance highlight this year's proxy agenda.IVR
Proxy filing20 Mar 2026 - Book value per share rose 3.7% to $8.72, with an 8.0% economic return and higher dividend.IVR
Q4 20252 Feb 2026 - Book value per share fell 8% in Q2, but distributable earnings and dividend remained stable.IVR
Q2 20241 Feb 2026 - Book value dropped 4.8% in Q4, with net loss and improved capital structure amid volatility.IVR
Q4 202423 Dec 2025 - Shelf registration allows up to $650M in securities for REIT investment and capital needs.IVR
Registration Filing16 Dec 2025 - Board seeks approval for director elections, executive pay, and auditor ratification amid strong governance.IVR
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification up for vote at May 2025 meeting.IVR
Proxy Filing1 Dec 2025 - Earnings rebounded in Q1 2025, but book value fell as volatility and risks persisted.IVR
Q1 202525 Nov 2025